Report on Psychedelics

Conversations: Spencer Hawkswell, Therapsil

Episode Summary

We spoke with Spencer Hawkswell of Therapsil about his organization's effort to gain psychedelic exemptions for terminally ill patients.

Episode Notes

Learn more about Therapsil:

Stay up to date with the latest in the business of psychedelics by subscribing to our weekly briefing: